|
Age (years)
|
45.3 ± 13.0
|
41.6 ± 12.4
|
|
ESRD (months)
|
29 (0–168)
|
33 (0–120)
|
|
Dialysis status:
| | |
|
Haemodialysis (N)
|
34
|
32
|
|
Peritoneal dialysis (N)
|
13
|
13
|
|
Pre-dialysis (N)
|
2
|
4
|
|
Haemodialysis, venous access: Arterio-venous fistulae/permanently haemodialysis catheter (N)
|
15/19
|
15/17
|
|
Tx status (living donor/deceased donor)
|
22/27
|
26/23
|
|
Myocardial infarction (N)
|
2
|
2
|
|
Smoking (N)
|
15
|
14
|
|
Stroke (N)
|
3
|
2
|
|
Diabetes (N)
|
3
|
5
|
|
Impaired fasting glucose (N)
|
1
|
2
|
|
Impaired glucose tolerance (N)
|
21
|
13
|
|
Normal glucose tolerance (N)
|
24
|
29
|
|
Fasting plasma glucose (mmol/L)
|
5.0 ± 0.4
|
5.1 ± 0.5
|
|
OGTT 120min(mmol/L)
|
8.0 ± 2.1
|
7.7 ± 2.1
|
|
ISI (index)
|
7.4 ± 4.1
|
7.9 ± 4.9
|
|
BMI (kg/m2)
|
24.2 ± 3.8
|
24.5 ± 3.6
|
|
PWV (m/s)
|
8.2 (5.6-15.8)
|
6.8 (5.2-16.4)*
|
|
AIX (%)
|
27 (-10;56)
|
20 (-7;50)
|
|
FMD (%)
|
3.8 (-8.3;19.2)
|
3.5 (-6.8;19.1)
|
|
NID (%)
|
10.5 (2.9;27.1)
|
11.5 (2.0;27.2)
|
|
Systolic blood pressure (mmHg)
|
143 ± 25
|
140 ± 19
|
|
Diastolic blood pressure (mmHg)
|
85 ± 12
|
84 ± 13
|
|
Number of antihypertensive drugs
|
2 (0–5)
|
3 (0–6)*
|
|
P-C-reactive protein (mg/L)
|
2 (1–40)
|
2 (1–21)
|
|
P-Homocystein (umol/L)
|
21 (11–62)
|
22 (12–150)
|
|
P-PTH (pmol/L)
|
21 (2–100)
|
20 (4–156)
|
|
P-ionized calcium (mmol/L)
|
1.19 ± 0.09
|
1.21 ± 0.09
|
|
P-phosphate (mmol/L)
|
1.8 ± 0.4
|
2.0 ± 0.6
|
